(Total Views: 170)
Posted On: 08/04/2021 9:28:38 AM
Post# of 107286
$ACER Acer Therapeutics plans clinical trial of Edsivo in connective-tissue disorder; Following a recent Type B meeting with the FDA, Acer Therapeutics (NASDAQ:ACER), plans to conduct clinical trial of Edsivo (celiprolol) in patients with COL3A1+ vascular Ehlers-Danlos Syndrome (vEDS). https://seekingalpha.com/news/3705018-acer-th...e-disorder
(0)
(0)
